Skip to content

Synopsys

US · SNPS #304 by market cap Listed 1970
502.67 -2.50 -0.49%
Live - 5344 symbols - heartbeat 77s ago · 2026-10-08 07:00
Pre-market 498.25 -0.88%
After-hours 503.00 +0.07%
Overnight 499.99 -0.53%
Market cap
96.33B
P/B
3.09
EPS
8.04
Reader sentiment Are you bullish or bearish on SNPS?

Anonymous reader poll. Unscientific, not investment advice.

✦ Quant Ownership Signal how this is computed

Distributing
  • The number of reporting institutions decreased by 15 in the most recent period (2026/Q3).
  • Total institutional ownership fell 0.2 percentage points.

Institutional ownership

Held by institutions
94.77% -0.23pp
Institutions
1,821 -15
As of
2026/Q3 vs. prior period

Ownership vs. money flow

Aligned

Institutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Holder types

Mutual Fund76.54%
Hedge Fund4.69%
Public Company4.26%
VC/PE Fund2.65%
Government Pension Fund2.39%
Private Company2.17%
Sovereign Wealth Fund0.92%
Individual/Insider0.45%
Family Office/Trust0.40%
Other5.53%

Top holders

BlackRock 8.46%
Vanguard Capital Management, LLC 7.09%
State Street Global Advisors 4.73%
Invesco Capital Management LLC 3.02%
UBS Asset Management 2.86%
FMR 2.72%
Other 73.84%
GPU Ventures (NVIDIA) 2.52%
Geode Capital Management, LLC 2.35%
Vanguard Portfolio Management, LLC 2.34%
Van Eck Associates Corporation 1.80%

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 29 buys · 21 sells

NameRoleStake
Aart de Geus Chairperson & CEO 0.23%
Ajei Gopal Director 0.09%
Sassine Ghazi President 0.04%
Sudhindra Kankanwadi Senior VP of Finance, Chief Accounting Officer & Corporate Controller 0.01%
Roy Vallee Lead Independent Director 0.01%
John Runkel General Counsel 0.01%
Janet Lee General Counsel 0.01%
Bruce Chizen Independent Director 0.01%
Shelagh Glaser Chief Financial Officer 0.01%
Janice Chaffin Independent Director 0.01%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-09-14 Sassine Ghazi President Derivative Exercise and Sale -14,604 $135.88–374.88
2026-09-10 Janet Lee General Counsel Derivative Exercise and Sale -993 $397.38
2026-09-10 Janet Lee General Counsel Derivative Exercise and Retained +1,290 --
2026-08-31 Aart de Geus Chairperson & CEO Derivative Exercise and Sale -49,641 $135.88–441.76
2026-08-31 Janet Lee General Counsel Derivative Exercise and Sale -304 $414.82
2026-08-31 Janet Lee General Counsel Derivative Exercise and Retained +395 --
2026-08-30 Aart de Geus Chairperson & CEO Other Acquisition +22 $360.96
2026-08-30 Michael Ellow Chief Revenue Officer Other Acquisition +27 $360.96
2026-08-30 Sudhindra Kankanwadi Senior VP of Finance, Chief Accounting Officer & Corporate Controller Other Acquisition +27 $360.96
2026-08-30 Sassine Ghazi President Other Acquisition +27 $360.96
2026-08-27 Aart de Geus Chairperson & CEO Derivative Exercise and Sale -25,000 $135.88–445.55
2026-08-15 Janet Lee General Counsel Derivative Exercise and Sale -318 $421.50
2026-08-15 Janet Lee General Counsel Derivative Exercise and Retained +411 --
2026-06-14 Aart de Geus Chairperson & CEO Derivative Exercise and Sale -156 $454.38
2026-06-14 Aart de Geus Chairperson & CEO Derivative Exercise and Retained +293 --
2026-06-14 Michael Ellow Chief Revenue Officer Derivative Exercise and Sale -2,543 $454.38
2026-06-14 Michael Ellow Chief Revenue Officer Derivative Exercise and Retained +2,585 --
2026-06-14 Sudhindra Kankanwadi Senior VP of Finance, Chief Accounting Officer & Corporate Controller Derivative Exercise and Sale -249 $454.38
2026-06-14 Sudhindra Kankanwadi Senior VP of Finance, Chief Accounting Officer & Corporate Controller Derivative Exercise and Retained +471 --
2026-06-14 Sassine Ghazi President Sale to Issuer -1,492 $454.38

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-10-08 07:00:00 · For reference only, not investment advice and not tailored to your situation.